News

Bluejay Therapeutics Receives Positive Opinion on Orphan Designation from the European Medicines Agency for BJT-778 for the Treatment of Chronic Hepatitis D

SAN MATEO, Calif., May 29, 2024 (GLOBE NEWSWIRE) -- Bluejay Therapeutics, a private clinical-stage biopharmaceutical company focused on viral and…

2 years ago

Black Diamond Therapeutics to Participate in Jefferies Global Healthcare Conference

CAMBRIDGE, Mass., May 29, 2024 (GLOBE NEWSWIRE) -- Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a clinical-stage oncology company developing MasterKey…

2 years ago

Lipella Pharmaceuticals Announces Abstract Publication at 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

Abstract highlighting new preclinical data from LP-50 in non-muscle invasive bladder cancerPITTSBURGH, May 29, 2024 (GLOBE NEWSWIRE) -- Lipella Pharmaceuticals…

2 years ago

Spinogenix Announces FDA Clearance of IND Application for SPG302, a Novel Therapy for the Treatment of ALS

SPG302 is being developed as a once-a-day pill with the potential to regenerate synapses to reverse declines in cognitive and…

2 years ago

Collegium to Participate in Jefferies Global Healthcare Conference

STOUGHTON, Mass., May 29, 2024 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified specialty pharmaceutical company committed to…

2 years ago

FendX Announces New Development Opportunity of Its Spray Nano-Coating That Uses AI and Sensors to Detect Contamination on Surfaces

Surface protection nanotechnology combined with AI and colorimetric sensors to detect bacteriaOakville, Ontario--(Newsfile Corp. - May 29, 2024) - FendX…

2 years ago

Bioss Antibodies and Bioz Launch Collaboration to Bring Real-Time Citation Data to Researchers

PALO ALTO, CA / ACCESSWIRE / May 29, 2024 / Bioz, Inc., a leading AI software company in Silicon Valley,…

2 years ago

Delivra Health Brands Announces Grant of Incentive Stock Options

Vancouver, British Columbia--(Newsfile Corp. - May 28, 2024) - Delivra Health Brands Inc. (TSXV: DHB) (OTCQB: DHBUF) ("Delivra Health" or…

2 years ago

Medicure Reports Financial Results for Quarter Ended March 31, 2024 and Annual General Meeting Director Election Results

WINNIPEG, MB / ACCESSWIRE / May 28, 2024 / Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTC PINK:MCUJF), a company focused…

2 years ago

Wilmington Eye Now Offering iDose(R) TR as a New Treatment Option to Reduce Eye Pressure in Patients With Ocular Hypertension and Open-Angle Glaucoma

iDose TR helps patients with glaucoma take long-term control of high eye pressure.WILMINGTON, NC / ACCESSWIRE / May 28, 2024…

2 years ago